ProShare Advisors LLC acquired a new stake in shares of TriMas Co. (NASDAQ:TRS - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 11,435 shares of the industrial products company's stock, valued at approximately $281,000.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Bank of America Corp DE raised its position in shares of TriMas by 127.3% during the fourth quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company's stock worth $86,400,000 after purchasing an additional 1,967,738 shares during the period. Bellecapital International Ltd. purchased a new stake in shares of TriMas during the fourth quarter valued at $29,160,000. Raymond James Financial Inc. purchased a new stake in shares of TriMas during the fourth quarter valued at $6,698,000. Kennedy Capital Management LLC lifted its holdings in shares of TriMas by 94.8% during the fourth quarter. Kennedy Capital Management LLC now owns 485,721 shares of the industrial products company's stock valued at $11,944,000 after purchasing an additional 236,346 shares during the last quarter. Finally, Advisory Research Inc. lifted its holdings in shares of TriMas by 41.2% during the fourth quarter. Advisory Research Inc. now owns 754,089 shares of the industrial products company's stock valued at $18,543,000 after purchasing an additional 220,000 shares during the last quarter. Institutional investors own 99.42% of the company's stock.
TriMas Stock Down 1.0%
TriMas stock traded down $0.27 during mid-day trading on Friday, hitting $26.35. The company's stock had a trading volume of 331,894 shares, compared to its average volume of 334,550. TriMas Co. has a 52-week low of $19.33 and a 52-week high of $28.51. The company has a market cap of $1.07 billion, a PE ratio of 41.17 and a beta of 0.58. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. The firm's 50 day moving average is $23.20 and its 200 day moving average is $24.01.
TriMas (NASDAQ:TRS - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $0.46 EPS for the quarter, topping the consensus estimate of $0.43 by $0.03. TriMas had a net margin of 2.93% and a return on equity of 9.21%. The business had revenue of $241.67 million during the quarter, compared to analysts' expectations of $235.41 million. During the same period last year, the company posted $0.37 earnings per share. The firm's quarterly revenue was up 6.4% compared to the same quarter last year. On average, analysts anticipate that TriMas Co. will post 1.69 earnings per share for the current year.
TriMas Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, May 13th. Stockholders of record on Tuesday, May 6th were paid a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date of this dividend was Tuesday, May 6th. TriMas's dividend payout ratio (DPR) is presently 20.78%.
Analyst Ratings Changes
Several equities research analysts have recently commented on the company. BWS Financial reaffirmed a "buy" rating and set a $40.00 target price on shares of TriMas in a report on Wednesday, April 30th. Wall Street Zen raised shares of TriMas from a "hold" rating to a "buy" rating in a research note on Sunday.
View Our Latest Stock Analysis on TriMas
Insider Transactions at TriMas
In other TriMas news, CFO Scott A. Mell sold 2,218 shares of the stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $22.54, for a total transaction of $49,993.72. Following the transaction, the chief financial officer now directly owns 26,288 shares of the company's stock, valued at $592,531.52. This represents a 7.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Shawn Sedaghat bought 72,937 shares of the stock in a transaction on Thursday, May 22nd. The shares were acquired at an average cost of $26.16 per share, for a total transaction of $1,908,031.92. Following the completion of the transaction, the director now directly owns 1,883,758 shares of the company's stock, valued at approximately $49,279,109.28. The trade was a 4.03% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 1,770,195 shares of company stock valued at $43,736,754. 14.20% of the stock is owned by insiders.
TriMas Company Profile
(
Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Stories

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report